首頁 > 市場調查報告書 > 醫療設備

病患監測血糖監測

市場調查報告書

商品編碼

1424325

糖尿病監測設備市場：依產品類型、按適應症、依最終用戶、按地區

Diabetes Monitoring Devices Market, By Product Type, By Indication, By End User, By Geography

出版日期: 2024年01月04日 | 出版商:

Coherent Market Insights | 英文 170 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

全球糖尿病監測設備市場規模預計將從 2023 年的 109 億美元增加到 2030 年的 189 億美元，預測期內複合年成長率為 8.2%。

報告範圍		報告詳情
基準年	2022年	2023/2024年市場規模	109億美元
實際資料	2018-2021	預測期	2023-2030
預測期間 2023/2024 至 2030/2031 年複合年成長率：	8.20%	2030/2031價值預測	189億美元

圖 1. 2023 年糖尿病監測設備按地區分類的全球市場佔有率(%)

糖尿病患者和臨床醫生使用血糖值監測儀來監測和控制患者的血糖值。這些設備大多數用於醫院外的患者。這些患者中有許多是老年人，行動能力有限，且視力受損。血糖值儀有一個測量端口，患者將塗塗布血液的小型校準測試條插入其中進行分析。為了適應靈活性有限的用戶，測試條不能太小以至於用戶無法操作。

市場動態：

全球糖尿病盛行率的不斷上升是推動糖尿病監測設備市場成長的主要因素。根據國際糖尿病聯盟的最新資料，2021年約有5.37億成年人患有糖尿病，預計2045年將增加至7.83億人。糖尿病對低收入和中等收入國家的影響尤其嚴重，每年導致超過 120 萬人死亡。全球糖尿病患者人數不斷增加，健康意識不斷提高，人們越來越重視有效的血糖監測和疾病管理。

然而，這個市場也面臨一定的挑戰。醫療保健專業人員操作複雜設備並將其涵蓋治療計劃的持續培訓成本也導致了價格上漲。政府透過報銷計畫進行的有限干預進一步限制了糖尿病患者的負擔能力。科技可望徹底改變糖尿病管理，但只有解決價格障礙，它的好處才能惠及大眾。除非開發出替代方案，使技術創新更便宜、更容易獲得，否則高價格將繼續限制市場擴張，特別是在開發中地區。

儘管存在這些挑戰，市場仍存在一些成長機會。新的穿戴式微創技術的發展有望徹底改變糖尿病監測。早期的例子包括連續血糖監測系統，不需要刺穿手指，並且可以佩戴長達 14 天。此外，還透過實驗開發了一種貼片式感測器，可以輕鬆提取組織液。如果此類解決方案變得經濟實惠且廣泛可用，它們可能有助於將管理從不一致的自我記錄轉變為近乎持續的自動監控。這可能使糖尿病患者能夠透過知情和及時的干涉來更好地控制他們的疾病。

本研究的主要特點

該報告詳細分析了全球糖尿病監測設備市場，並提供了以2022年為基準年的預測期（2023-2030）的市場規模和年複合成長率（CAGR%）。
它還揭示了各個細分市場的潛在商機，並為該市場說明了一系列有吸引力的投資提案。
它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
它根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球糖尿病監測設備市場的主要企業。
該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
全球糖尿病監測設備市場報告滿足該行業的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者和財務分析師。
相關人員可以透過用於分析全球糖尿病監測設備市場的各種策略矩陣來促進他們的決策。

北美洲
美國
加拿大
歐洲
德國
英國
西班牙
法國
義大利
俄羅斯
其他歐洲國家
亞太地區
中國
印度
日本
澳洲
韓國
ASEAN
其他亞太地區
拉丁美洲
巴西
阿根廷
墨西哥
其他拉丁美洲
中東
海灣合作理事會國家
以色列
其他中東地區
非洲
南非
北非
中部非洲

第9章競爭形勢

公司簡介
- i-SENS, Inc.
- Ascensia Diabetes Care Holdings AG.
- Bayer AG
- Hoffmann-La Roche Ltd
- Johnson &Johnson Services, Inc.
- Medtronic
- Dexcom
- Abbott
- Labiotech UG
- ARKRAY, Inc.
- Cnoga
- Sanofi
- Lifescan
- Analysts'Views

第10章

參考
調查方法
關於出版商

簡介目錄

Product Code: CMI1278

Global diabetes monitoring devices market size is expected to reach US$ 18.90 Bn by 2030, from US$ 10.90 Bn in 2023, exhibiting a compound annual growth rate (CAGR) of 8.2% during the forecast period.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023/2024:	US$ 10.90 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023/2024 to 2030/2031 CAGR:	8.20%	2030/2031 Value Projection:	US$ 18.90 Bn

Figure 1. Global Diabetes Monitoring Devices Market Share (%), By Region, 2023

Diabetes Monitoring Devices Market - IMG1

Blood glucose monitors are used by diabetic patients and clinicians to monitor and to help control a patient's blood glucose level. Most of these devices are used by patients outside the hospital setting. Many of these patients are elderly, with limited manual dexterity and impaired vision. Blood glucose monitors have a reading port into which patients place a small calibrated test strip, onto which they have applied blood, for analysis. In order to accommodate users with limited manual dexterity, the test strips cannot be too small by making the strip difficult for the user to handle.

Market Dynamics:

Growing prevalence of diabetes across the globe is a major factor driving the growth of diabetes monitoring devices market. According to the latest data by the International Diabetes Federation, approximately 537 million adults were living with diabetes in 2021 which is projected to rise to 783 million by 2045. Diabetes disproportionately affects lower and middle-income countries and accounts for over 1.2 million deaths each year. With the rising diabetic population worldwide and increasing health awareness, there is greater emphasis on efficient glucose monitoring and management of the disease.

However, the market also faces certain challenges. The costs involved in continuous training of healthcare providers to operate and integrate advanced devices into treatment plans also contribute to higher prices. Limited government intervention through reimbursement schemes further restrains affordability of diabetic patients. While technology holds promise to revolutionize diabetes management, its benefits can only percolate to masses if pricing obstacles are addressed. Unless alternatives are developed to make innovation more affordable and accessible, high prices will continue limiting market expansion especially in less developed regions.

Despite these challenges, the market presents several opportunities for growth. The development of novel wearable and minimally-invasive technologies is expected to transform diabetes monitoring. A few early examples include continuous glucose monitoring systems that do not require finger pricks and can be worn for up to 14 days. Patch-like sensors have also been trialed that extract interstitial fluid with little pain or hassle. If such solutions become widely accessible in an affordable way, they may help shift management from inconsistent self-tracking to near-constant automated oversight. This could help diabetics better control their condition through informed timely interventions.

Key features of the study:

This report provides in-depth analysis of the global diabetes monitoring devices market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global diabetes monitoring devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include i-SENS, Inc., Ascensia Diabetes Care Holdings AG., Bayer AG, F. Hoffmann-La Roche Ltd, Johnson & Johnson Services, Inc., Medtronic, Dexcom, Abbott, Labiotech UG, ARKRAY, Inc., Cnoga, Sanofi, and Lifescan
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global diabetes monitoring devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global diabetes monitoring devices market

Global Diabetes Monitoring Devices Market Detailed Segmentation:

By Product Type:
- Self-Monitoring Blood Glucose Devices
- Continuous Glucose Monitoring Devices
By Indication:
- Type-I Diabetes
- Type-II Diabetes
- Gestational Diabetes
By End User:
- Hospitals
- Clinics
- Ambulatory Surgical Center
- Home Care Settings
- Others
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Top Companies in the Global Diabetes Monitoring Devices Market:
- i-SENS, Inc.
- Ascensia Diabetes Care Holdings AG.
- Bayer AG
- Hoffmann-La Roche Ltd
- Johnson & Johnson Services, Inc.
- Medtronic
- Dexcom
- Abbott
- Labiotech UG
- ARKRAY, Inc.
- Cnoga
- Sanofi
- Lifescan

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Indication
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Growing prevalence of diabetes
- Technological advancements in devices
Key Highlights
Regulatory Scenario
Recent Trends
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Mergers, Acquisitions and Collaborations

4. Global Diabetes Monitoring Devices Market- Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Diabetes Monitoring Devices Market, By Product Type, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Self-Monitoring Blood Glucose Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Continuous Glucose Monitoring Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Global Diabetes Monitoring Devices Market, By Indication, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Type-I Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Type-II Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Gestational Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

7. Global Diabetes Monitoring Devices Market, By End User, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn )
Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Ambulatory Surgical Center
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Global Diabetes Monitoring Devices Market, By Region, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2019 -2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
GCC Countries
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)
South Africa
North Africa
Central Africa